Bodycote Regulatory News (BOY)

          www.bodycote.com

16 March 2026

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that in the week 9 March to 13 March 2026, it purchased for cancellation the following number of its ordinary shares of 17 3 / 11 pence each (Ordinary Shares) through Barclays Bank plc, as part of the first £40 million tranche of the £80 million share repurchase programme announced on 11 March 2026 (the ‘Programme’). All Ordinary Shares were purchase from Barclays Bank plc as an ‘on exchange’ transaction subject to the rules of the London Stock Exchange.

Since the commencement of this Programme, the Company has purchased 55,538 Ordinary Shares in aggregate for cancellation from Barclays Bank plc in accordance with the Programme. Following the above purchases and cancellation of these Ordinary Shares, the Company will have 172,707,052 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a breakdown of the individual trades made by Barclays as principal on behalf of the Company in connection with the above purchases is detailed in the attachment. Purchases made under Programme will be announced on a weekly basis. 260316 - Bodycote Buyback - Weekly Transactions.pdf

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Edward Knight

Tel: +44 203 727 1340